Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
QNCX
$32.23
-4.50%
QNCX
· Quince Therapeutics, Inc.
$32.23
-1.52 (-4.50%)
At close · Aug 31
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company concluded that substantial doubt about the Company's ability to continue as a going concern continues to exist within one year after the date these financial statements are available to be issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$34.33M
Shares
1.02M
All earnings calls
Earnings call · FY2022 Q2
Quince Therapeutics, Inc. (QNCX) Q2 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$102.00
Net income
-$16.56M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 1, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 9, 2022 · complete as-filed document